Characterisation of anti‐alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin

OBJECTIVES: MEDI4893 is a novel, long‐acting human monoclonal antibody targeting Staphylococcus aureus (SA) alpha toxin (AT). This report presents the results of the exploratory analyses from a randomised phase 1 dose‐escalation study in healthy human subjects receiving single intravenous MEDI4893 d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Transl Immunology
Autors principals: Ruzin, Alexey, Wu, Yuling, Yu, Li, Yu, Xiang‐Qing, Tabor, David E, Mok, Hoyin, Tkaczyk, Christine, Jensen, Kathryn, Bellamy, Terramika, Roskos, Lorin, Esser, Mark T, Jafri, Hasan S
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822409/
https://ncbi.nlm.nih.gov/pubmed/29484186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars